SCOTTSDALE, AZ, August 24, 2020 – – CBD Life Sciences Inc. (OTC PINK: CBDL) (“The Company”) wholly-owned subsidiary, LBC Bioscience Inc. (“LBC”) has signed an exclusive Agreement with a Phoenix, Arizona based Cannabis, Hemp and CBD Laboratory to manufacture CBD lined drinking straws which the Company anticipates will be a first to market product, providing a convenient and effective means of delivering pure CBD isolate while you drink your favorite beverage.
The biodegradable drinking straws are packed with 25mg of pure CBD isolate and will be available in various quantities to satisfy both consumer and commercial consumption.
LBC’s lab partner specially formulates all products to be infused with a Pure CBD Isolate , zero THC, with certified GMP formulators and third-party labs to always ensure high-quality, potency, and clean products.
LBC is in the process of obtaining patent and trademarks for the product which will be manufactured exclusively for LBC by the lab partner and will feature LBC branding.
Company founder and CEO Lisa Nelson states, “We are thrilled to have cultivated a relationship here. There are many types of CBD delivery systems available, but I am confident we will be first to market with this innovative solution for consumers, dispensaries, wellness centers and other potential markets alongside the Company’s other endeavors in this rapidly growing sector.”
According to a recent report by Data Bridge Market Research, with consideration of COVID-19 impact overall, CBD Oil Market is expected to witness growth at a rate of 31.90% for the forecast period of 2020 to 2027.
Learn more at:
JOIN US ON SOCIAL MEDIA!
About LBC Bioscience Inc.:
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Hand Sanitizer, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC’s products can be viewed and purchased on the Company’s website at www.lbcbioscienceinc.com.
Ten Associates LLC
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.